Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 291

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 291
---
, April 2023 Warrants, September 2023 Warrants and January 2024 Warrants were exercised into 306,172 shares, for gross proceeds of $402,206. |

| (ix) | On July 4, 2024, 64,617 common shares with a fair value of $103,387 were issued to providers of investor services in payment of services. |

| (xi) | During the period between July 4, 2024 and July 8, 2024, 134,868 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $256,252 at the time of issuance. |

F-50 CLEARMIND MEDICINE INC. Notes to the Condensed Interim Consolidated Financial Statements For the three and nine months ended July 31, 2025 and 2024 (Expressed in United States Dollars) (Unaudited)

| 7. | Warrants |

The following table summarizes
the changes in the Company’s warrants:

|                                                                                     |     | Number of 
 warrants  |            |   |     | Historic weighted 
 average           
 exercise          
 price per warrant 
 shares            |          |
|:------------------------------------------------------------------------------------|:----|:----------|-----------:|:--|:----|:------------------|---------:|
| Balance, October 31, 2023                                                           |     |           | 11,231,465 |   |     | $                 |     7.90 |
| Issuance of January 2024 warrants (*)                                               |     |           |  1,500,000 |   |     |                   |     1.60 |
| Exercise of warrants                                                                |     |           | (8,293,585 | ) |     |                   |     2.62 |
| Expiration of warrants                                                              |     |           |     (8,333 | ) |     |                   |    98.43 |
| Balance, October 31, 2024                                                           |     |           |  4,429,547 |   |     | $                 |     1.57 |
| Number of shares to be issued from the exercise of these warrants, October 31, 2024 |     |           |  2,549,311 |   |     |                   |          |
| Balance, October 31, 2024                                                           |     |           |  4